Efavirenz

Discover Efavirenz, an antiretroviral medication used to treat HIV infection. Learn about its mechanism, medical uses, dosage, side effects, and drug inter

Efavirenz Efavirenz HIV treatment Efavirenz mechanism of action Efavirenz side effects Efavirenz dosage NNRTI drugs HIV antiretroviral therapy Efavirenz drug interactions
🏷 ATC Code: J05AG03 📂 Non-nucleoside reverse transcriptase inhibitors 🕐 Updated: Mar 13, 2026 ✓ Medical Reference

Looking to order Efavirenz?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Efavirenz?

Efavirenz is an antiretroviral medication widely used in the management of human immunodeficiency virus type 1 (HIV-1) infection. As a crucial component of highly active antiretroviral therapy (HAART), it belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). This medication helps to control the virus by preventing it from replicating within the body, thereby reducing the viral load and improving the immune system's function. It is not a cure for HIV, but rather a vital tool in managing the disease, allowing individuals with HIV to live longer, healthier lives. Efavirenz is typically prescribed as part of a combination regimen with other antiretroviral drugs to enhance efficacy and minimize the development of drug resistance.

How Does it Work?

The mechanism of action of Efavirenz is centered on its ability to inhibit the enzyme reverse transcriptase, which is essential for the HIV life cycle. Specifically, Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike nucleoside reverse transcriptase inhibitors (NRTIs), NNRTIs do not compete with nucleoside triphosphates but instead bind directly to a specific site on the reverse transcriptase enzyme. This binding induces a conformational change that inactivates the enzyme, preventing it from converting viral RNA into DNA. Without this crucial step, the HIV virus cannot integrate its genetic material into the host cell's DNA, effectively halting its replication and reducing the viral load in the body. This targeted action makes Efavirenz a potent agent against HIV-1.

Medical Uses

The primary medical use of Efavirenz is in the treatment of HIV-1 infection in adults, adolescents, and children weighing at least 3.5 kg. It is always used in combination with other antiretroviral agents, forming the cornerstone of highly active antiretroviral therapy (HAART). This combination approach is critical for achieving optimal viral suppression, preventing the emergence of drug-resistant strains, and prolonging the patient's life. Efavirenz is effective in both treatment-naive patients and those who have previously received other antiretroviral therapies. Its role is to reduce the viral load to undetectable levels, increase CD4 cell counts, and improve overall immune function, thereby reducing the risk of opportunistic infections and other HIV-related complications. Regular monitoring of viral load and CD4 counts is essential to assess treatment effectiveness.

Dosage

The standard adult dosage for Efavirenz is 600 mg taken orally once daily. For optimal absorption and to minimize central nervous system (CNS) side effects, it is generally recommended to take Efavirenz on an empty stomach, preferably at bedtime. This helps to reduce peak plasma concentrations and the associated neurological symptoms such as dizziness and vivid dreams. Pediatric dosing is weight-based and should be carefully determined by a healthcare professional. Adherence to the prescribed dosage regimen is paramount for the success of HIV treatment. Missing doses can lead to suboptimal drug levels, increasing the risk of viral resistance and treatment failure. Patients should consult their doctor or pharmacist for precise dosing instructions and guidance on managing potential side effects.

Side Effects

Like all medications, Efavirenz can cause side effects, though not everyone experiences them. Common side effects often include neurological symptoms such as dizziness, insomnia, abnormal dreams, difficulty concentrating, and drowsiness. These CNS effects typically occur within the first few weeks of treatment and often improve over time. Other common side effects may include rash, nausea, diarrhea, and headache. More serious side effects, though less common, can include severe skin reactions (e.g., Stevens-Johnson syndrome), liver problems (hepatotoxicity), and psychiatric symptoms such as severe depression, aggression, paranoia, and suicidal thoughts. Patients experiencing severe rash, yellowing of the skin or eyes, dark urine, or significant mood changes should seek immediate medical attention. Regular monitoring by a healthcare provider is essential to manage and mitigate these risks.

Drug Interactions

Efavirenz has a complex drug interaction profile due to its metabolism through the cytochrome P450 enzyme system, particularly CYP3A4 and CYP2B6. It can act as an inducer of these enzymes, potentially increasing the metabolism of other drugs and reducing their effectiveness, or as an inhibitor, leading to increased levels of co-administered drugs. Significant interactions can occur with medications such as rifampin (used for tuberculosis), voriconazole (an antifungal), carbamazepine (an anticonvulsant), and certain benzodiazepines. St. John's Wort, a herbal supplement, can also significantly reduce Efavirenz levels and should be avoided. Furthermore, Efavirenz can reduce the effectiveness of hormonal contraceptives, necessitating alternative or additional birth control methods. Patients must inform their healthcare provider about all prescription drugs, over-the-counter medications, and herbal supplements they are taking to prevent potentially dangerous drug interactions.

FAQ

  • Q: Is Efavirenz a cure for HIV?
    A: No, Efavirenz is not a cure for HIV. It is an antiretroviral medication that helps manage the infection by reducing the viral load and improving immune function.
  • Q: Can I take Efavirenz during pregnancy?
    A: Efavirenz has been associated with potential risks in early pregnancy, though current guidelines often consider it an option depending on the specific circumstances and discussion with a healthcare provider. Always consult your doctor if you are pregnant or planning to become pregnant.
  • Q: What should I do if I miss a dose of Efavirenz?
    A: If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
  • Q: How should Efavirenz be stored?
    A: Efavirenz should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Products containing Efavirenz are available through trusted online pharmacies. You can browse Efavirenz-based medications at ShipperVIP or Medicenter.

Summary

Efavirenz is a critical antiretroviral medication classified as a non-nucleoside reverse transcriptase inhibitor (NNRTI), playing a pivotal role in the treatment of HIV-1 infection. Its mechanism involves inhibiting the viral enzyme reverse transcriptase, thereby preventing HIV replication. Always used as part of a combination therapy, Efavirenz helps to suppress the viral load and enhance the immune system. While generally effective, it is associated with common side effects, particularly neurological symptoms, and has a complex profile of drug interactions. Adherence to prescribed dosage and close monitoring by healthcare professionals are essential for maximizing its benefits and managing potential risks. Patients should always discuss their complete medical history and all concurrent medications with their doctor to ensure safe and effective HIV management with Efavirenz.